Michael J. Dapp, Ph.D.
|2012||Pharmacology||University of Minnesota, Twin Cities, Minneapolis, MN|
Area:Microbiology Biology, Pharmacology, Virology Biology
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Dapp MJ, Bonnac L, Patterson SE, et al. (2014) Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63|
|Rawson JM, Heineman RH, Beach LB, et al. (2013) 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8|
|Dapp MJ, Patterson SE, Mansky LM. (2013) Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62|
|Dapp MJ, Heineman RH, Mansky LM. (2013) Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53|
|Dapp MJ, Holtz CM, Mansky LM. (2012) Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70|
|Dapp MJ, Clouser CL, Patterson S, et al. (2009) 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8|